SG11202104732UA - Methods for shrinking pituitary tumors - Google Patents
Methods for shrinking pituitary tumorsInfo
- Publication number
- SG11202104732UA SG11202104732UA SG11202104732UA SG11202104732UA SG11202104732UA SG 11202104732U A SG11202104732U A SG 11202104732UA SG 11202104732U A SG11202104732U A SG 11202104732UA SG 11202104732U A SG11202104732U A SG 11202104732UA SG 11202104732U A SG11202104732U A SG 11202104732UA
- Authority
- SG
- Singapore
- Prior art keywords
- shrinking
- methods
- pituitary tumors
- pituitary
- tumors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/32—Surgical cutting instruments
- A61B17/3205—Excision instruments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862758477P | 2018-11-09 | 2018-11-09 | |
| PCT/US2019/060548 WO2020097513A1 (en) | 2018-11-09 | 2019-11-08 | Methods for shrinking pituitary tumors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202104732UA true SG11202104732UA (en) | 2021-06-29 |
Family
ID=70551489
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202104732UA SG11202104732UA (en) | 2018-11-09 | 2019-11-08 | Methods for shrinking pituitary tumors |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10946005B2 (en) |
| EP (1) | EP3876936A4 (en) |
| JP (1) | JP7159470B2 (en) |
| KR (1) | KR102651146B1 (en) |
| CN (1) | CN113015528A (en) |
| AU (1) | AU2019377864B2 (en) |
| BR (1) | BR112021008719A2 (en) |
| CA (1) | CA3117058C (en) |
| IL (1) | IL283043A (en) |
| MX (1) | MX2021005438A (en) |
| PH (1) | PH12021551023A1 (en) |
| SG (1) | SG11202104732UA (en) |
| UA (1) | UA125365C2 (en) |
| WO (1) | WO2020097513A1 (en) |
| ZA (1) | ZA202102652B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210107004A (en) * | 2018-12-20 | 2021-08-31 | 코어셉트 쎄라퓨틱스 인코포레이티드 | Imaging and treatment methods of somatostatin receptor-positive tumors |
| AU2020355094A1 (en) * | 2019-09-24 | 2022-04-14 | The Board Of Regents Of The University Of Texas System | Methods and systems for analyzing brain lesions with longitudinal 3D MRI data |
| EP4157274A1 (en) * | 2020-05-27 | 2023-04-05 | Corcept Therapeutics Incorporated | Concomitant administration of glucocorticoid receptor modulator relacorilant and cyp2c9 substrates |
| CN115697337A (en) * | 2020-05-27 | 2023-02-03 | 科赛普特治疗学股份有限公司 | Concurrent administration of glucocorticoid receptor modulators, rilacolan and paclitaxel (dual substrates for CYP2C8 and CYP3 A4) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8859774B2 (en) | 2012-05-25 | 2014-10-14 | Corcept Therapeutics, Inc. | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
| PL2854814T3 (en) * | 2012-05-25 | 2018-07-31 | Corcept Therapeutics, Inc. | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
| AU2016226451B2 (en) | 2015-03-02 | 2019-12-19 | Corcept Therapeutics, Inc. | Use of glucocorticoid receptor antagonist and somatostatin analogues to treat ACTH-secreting tumors |
| WO2017151613A1 (en) | 2016-03-01 | 2017-09-08 | Corcept Therapeutics, Inc. | The use of glucocorticoid receptor modulators to potentiate checkpoint inhibitors |
-
2019
- 2019-11-08 JP JP2021525281A patent/JP7159470B2/en active Active
- 2019-11-08 EP EP19881977.3A patent/EP3876936A4/en active Pending
- 2019-11-08 AU AU2019377864A patent/AU2019377864B2/en active Active
- 2019-11-08 BR BR112021008719-2A patent/BR112021008719A2/en unknown
- 2019-11-08 WO PCT/US2019/060548 patent/WO2020097513A1/en unknown
- 2019-11-08 CA CA3117058A patent/CA3117058C/en active Active
- 2019-11-08 KR KR1020217016943A patent/KR102651146B1/en active IP Right Grant
- 2019-11-08 MX MX2021005438A patent/MX2021005438A/en unknown
- 2019-11-08 UA UAA202103152A patent/UA125365C2/en unknown
- 2019-11-08 SG SG11202104732UA patent/SG11202104732UA/en unknown
- 2019-11-08 CN CN201980073411.4A patent/CN113015528A/en active Pending
- 2019-11-08 US US16/678,988 patent/US10946005B2/en active Active
-
2021
- 2021-02-25 US US17/185,133 patent/US20210177817A1/en active Pending
- 2021-04-21 ZA ZA2021/02652A patent/ZA202102652B/en unknown
- 2021-05-04 PH PH12021551023A patent/PH12021551023A1/en unknown
- 2021-05-09 IL IL283043A patent/IL283043A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102651146B1 (en) | 2024-03-25 |
| ZA202102652B (en) | 2022-09-28 |
| CA3117058C (en) | 2024-02-13 |
| US20200147065A1 (en) | 2020-05-14 |
| IL283043A (en) | 2021-06-30 |
| JP2022509051A (en) | 2022-01-20 |
| KR20210076149A (en) | 2021-06-23 |
| CN113015528A (en) | 2021-06-22 |
| MX2021005438A (en) | 2021-06-15 |
| AU2019377864A1 (en) | 2021-06-03 |
| EP3876936A1 (en) | 2021-09-15 |
| PH12021551023A1 (en) | 2022-02-21 |
| WO2020097513A1 (en) | 2020-05-14 |
| US10946005B2 (en) | 2021-03-16 |
| AU2019377864B2 (en) | 2023-03-16 |
| CA3117058A1 (en) | 2020-05-14 |
| US20210177817A1 (en) | 2021-06-17 |
| JP7159470B2 (en) | 2022-10-24 |
| EP3876936A4 (en) | 2022-08-17 |
| UA125365C2 (en) | 2022-02-23 |
| BR112021008719A2 (en) | 2021-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202102229RA (en) | Techniques for improving vnr-to-volte fallback | |
| IL260443B (en) | Anti-egfr combinations for treating tumors | |
| GB201816767D0 (en) | Apparatus | |
| IL260444B (en) | Anti-her2 combinations for treating tumors | |
| IL260442B (en) | Anti-cd20 combinations for treating tumors | |
| IL283043A (en) | Methods for shrinking pituitary tumors | |
| EP3606962A4 (en) | Methods for treating cd73hi tumors | |
| PL3748369T3 (en) | Integrated current-measuring apparatus | |
| GB201819259D0 (en) | Clamping apparatus | |
| IL280884A (en) | Methods for characterizing protein complexes | |
| GB2578969B (en) | Container-Manoeuvring Apparatus | |
| SG11202102549RA (en) | Methods for reducing condensation | |
| IL274013A (en) | Authentication for digital dyeing | |
| SG11202010335WA (en) | Techniques for performing secure operations | |
| IL280267A (en) | Patch | |
| GB2561885B (en) | An apparatus for enhancing visibility | |
| SG11202007131UA (en) | Patch | |
| GB201819575D0 (en) | Apparatus | |
| GB201811833D0 (en) | Patch | |
| GB201816928D0 (en) | Injection apparatus | |
| GB2571090B (en) | Multi-functional apparatus for groundworks | |
| GB201802021D0 (en) | Apparatus | |
| IL278096A (en) | Methods for determining vaccine potency | |
| IL268046A (en) | Peptides for therapy | |
| GB201916361D0 (en) | Apparatus |